Sort
82,697 grants matching “vaccine development”
MUCOSAL IMMUNITY AND INFECTION
$852,938Case Western Reserve University · P01 · FY2002 · AI
Early life B cell responses and inflammation following SARS-CoV-2 infection
$852,895Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Tetravalent dengue vaccine based on complex adenovirus vectors
$852,862Kanakatte Raviprakash · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2009 · AI
STATISTICAL &CLINICAL COORDINATING CENTER (SC)
$852,857Fred Hutchinson Cancer Research Center · N01 · FY2000 · AI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
$852,739Stephen Philip Schoenberger · La Jolla Institute For Immunology · U01 · FY2019 · DE
DISSEMINATED TUBERCULOSIS IN HIV INFECTION
$852,665Dartmouth College · R01 · FY2002 · AI
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
$852,537Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Developing Transmissible Antivirals by Exploiting Gene-Expression Circuitry
$852,500Leor S Weinberger · University Of California, San Diego · DP2 · FY2009 · OD
ApoVax104-HPV as a Novel Vaccine for Cervical Cancer
$852,358Kathryn J. Macleod · Apovax, Inc. · R44 · FY2009 · AI
COVID-19 vaccine in naive individuals and cancer patients
$851,991Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Reactions And Immunochemistry Of Carbohydrates
$851,975Pavol Kovac · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds
$851,964Ravi S Kane · Georgia Institute Of Technology · R01 · FY2023 · AI
Reverse Genetics To Forward The Pan-Lassa Fever Vaccine Lead Candidate ML29
$851,962Slobodan Paessler · University Of Texas Med Br Galveston · R56 · FY2018 · AI
Biodefense/Emerging Infection Vaccine Studies
$851,944Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Biodefense/Emerging Infection Vaccine Studies
$851,944Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$851,913James M Olson · Seattle Children'S Hospital · U01 · FY2025 · CA
VACCINATION FOR TREATMENT OF NICTOTINE DEPENDENCE
$851,874Nabi Biopharmaceuticals · U19 · FY2000 · DA
A San Francisco Street Youth Cohort: At Risk and HIV+
$851,604Anna-Barbara None Moscicki · University Of California, San Francisco · U01 · FY2008 · HD
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE
$851,522Alessandro Sette · La Jolla Institute For Immunology · U24 · FY2025 · CA
Multi-component HIV Intervention Packages for Chinese MSM
$851,487Sten H Vermund · Vanderbilt University · R01 · FY2012 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$851,359Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$851,270Chuck Squires · Pfenex, Inc. · N01 · FY2015 · AI
Trypanosome Transmission Biology in Tsetse
$851,229Serap Aksoy · Yale University · R01 · FY2022 · AI
Epigenomic analysis of primary immune cells from young and old animals
$851,161Myong-Hee Sung · National Institute On Aging · ZIA · FY2016 · AG
ARRA: Development of Universal Influenza Assays
$851,102Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI